Apex Consumer Court slaps Rs 35 lakh compensation on Johnson & Johnson for faulty hip replacement device Ruchika Sharma1 Oct 2024 12:35 PM ISTNew Delhi: In a significant ruling, the National Consumer Disputes Redressal Commission (NCDRC) has ordered Johnson & Johnson Limited to...
JnJ gets USFDA nod for Rybrevant plus standard of care chemotherapy for lung cancer treatment Ruchika Sharma21 Sept 2024 4:00 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) in...
JnJ seeks approval of nipocalimab to treat generalized myasthenia gravis Ruchika Sharma2 Sept 2024 4:29 PM ISTSpring House: Johnson & Johnson has announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug...
European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
JnJ chemotherapy free lung cancer treatment Rybrevant plus Lazcluze gets USFDA okay Ruchika Sharma21 Aug 2024 12:30 PM ISTNew Jersey: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT (amivantamab-vmjw) plus...
Johnson & Johnson to acquire V-Wave Ruchika Sharma21 Aug 2024 10:00 AM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire V-Wave Ltd., a privately-held...
DePuy Synthes unveils TriLEAP Lower Extremity Anatomic Plating System Ruchika Sharma11 Aug 2024 1:30 PM ISTWest Chester: Johnson & Johnson MedTech has announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has launched its...
JnJ gets USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma who are transplant-eligible Ruchika Sharma2 Aug 2024 11:30 AM ISTHorsham: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...
Johnson & Johnson beat estimates for Q2 profit, revenue Ruchika Sharma18 July 2024 4:53 PM ISTLondon:Johnson & Johnson exceeded expectations in its second-quarter profit and revenue announced on Wednesday, propelled by robust sales of its...
JnJ strengthens atopic dermatitis pipeline with acquisition of Yellow Jersey Therapeutics Ruchika Sharma14 July 2024 12:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Yellow Jersey, a demerged...
COVID vaccine supply deal dispute: JnJ to pay USD 50 million to Emergent Ruchika Sharma9 July 2024 5:49 PM ISTEmergent BioSolutions has said that Johnson & Johnson has agreed to settle claims arising from the termination of the manufacturing deal for the...
JnJ completes acquisition of Proteologix Ruchika Sharma23 Jun 2024 1:30 PM ISTNew Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of Proteologix, Inc., a privately-held...
